[Percutaneous drainage of refractory necrotizing tumors: experience in 9 patients].
OBJECTIVE
The ranking of percutaneous drainage treatment in necrolytic advanced tumours was assessed.


METHODS
9 patients with refractory symptomatic necrolytic tumours were treated for alleviation by percutaneous drainage. Additionally, an attempt to sclerose the necrotic cavity was performed in 6 patients (6 x mitoxantrone 30 mg/24 hrs, of which 1 x additionally 98% alcohol).


RESULTS
In 5 of the 9 patients symptomatic relief was obtained, but complete sclerosing of the necrotic cavity succeeded in only two patients. In two patients with necrotic tumours of the pelvis there was a bacterial superinfection of the tumour necrosis.


CONCLUSIONS
Percutaneous alleviation is only occasionally successful in patients with necrolytic tumours. Therapy becomes effective probably only in case of successful sclerosing of the tumorous cavity.
Görich
J
J
Radiologische Universitätsklinik Ulm.
Brensing
K A
KA
Kunze
V
V
Sokiranski
R
R
Rilinger
N
N
Müller-Miny
H
H
Brambs
H J
HJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D003536:Cystadenocarcinoma / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D004322:Drainage; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D006801:Humans; D007890:Leiomyosarcoma / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D008113:Liver Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D009336:Necrosis / Q000473:pathology / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D015911:Sclerotherapy; D014057:Tomography, X-Ray Computed; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy
D008942:Mitoxantrone
Perkutane Drainage von therapierefraktären nekrotisierenden Tumoren: Erfahrungen bei 9 Patienten.